Synthesis and antibacterial activity of tert-butyl [1-benzyl-2[(4-aryl-2- thiazolyl)hydrazono]ethyl]carbamate derivatives

Archiv der Pharmazie

Volumn 340, Issue 6, 2007, Pages 310-314

  Turan Zitouni, Gülhan ^a   Fehrentz, Jean Alain ^b   Chevallet, Pierre ^b   Martinez, Jean ^b   Kaplancikli, Zafer Asim ^a   Özdemir, Ahmet ^b   Arslanyolu, Muhittin ^a   Yildiz, Mehmet Taha ^a  

^a ANADOLU UNIVERSITY   (Turkey)

^b UNIV MONTPELLIER   (France)

Author keywords

Amino acid; Antibacterial activity; Thiazole

Indexed keywords

ANTIBIOTIC AGENT; BROMINE DERIVATIVE; TERT BUTYL (1 BENZYL 2 THIOSEMICARBAZONOETHYL)CARBAMATE; TERT BUTYL [1 BENZYL 2 [4 (4 PHENYL 2 THIAZOLYL)HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL [1 BENZYL 2 [[4 (3,4 DICHLOROPHENYL) 2 THIAZOLYL]HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL [1 BENZYL 2 [[4 (4 CHLOROPHENYL) 2 THIAZOLYL]HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL [1 BENZYL 2 [[4 (4 HYDROXYPHENYL) 2 THIAZOLYL]HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL [1 BENZYL 2 [[4 (4 METHOXYPHENYL) 2 THIAZOLYL]HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL [1 BENZYL 2 [[4 (4 METHYLPHENYL) 2 THIAZOLYL]HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL [1 BENZYL 2 [[4 (4 NITROPHENYL) 2 THIAZOLYL]HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL [1 BENZYL 2 [[4 [(2 HYDROXY 5 CHLORO)PHENYL)] 2 THIAZOLYL]HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL [1 BENZYL 2 [[4 [(2 HYDROXY 5 METHOXY)PHENYL)] 2 THIAZOLYL]HYDRAZONO]ETHYL]CARBAMATE; TERT BUTYL[1 BENZYL 2[(4 ARYL 2 THIAZOLYL)HYDRAZONO]ETHYL]CARBAMATE; THIOSEMICARBAZIDE; THIOSEMICARBAZONE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTEMIA; ARTICLE; BACILLUS CEREUS; BIOASSAY; CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTI-BACTERIAL AGENTS; ARTEMIA; BACILLUS CEREUS; CARBAMATES; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HYDRAZONES; LETHAL DOSE 50; MICROBIAL SENSITIVITY TESTS; THIAZOLES;

EID: 34250854524     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200600200     Document Type: Article

References (27)

1. B. A. Cunha, Drugs Today 1998, 34, 691-698.
2. S. B. Levy, Sci. Am. 1998, 278, 46-53.
3. M. Lipsitch, Trends Microbiol. 2001, 9, 438-444.
4. R. B. Silverman, Organic Chemistry of Drug Desing and Drug Action, Academic Press, San Diego, 1992.
5. J. S. Powers, R. E. W. Hancock, Peptides 2003, 24, 1681-1691.
6. R. M. Epand, H. J. Vogel, Biochim. Biophys. Acta 1999, 1462, 11-28.
7. J. Berdy, A. Aszalos, M. Bostian, K. L. McNitt in CRC Handbook of Antibiotic Compounds, (Ed.: J. Berdy), CRC Press, 1980; Vol. 4, Part 1, pp. 389-417.
8. H. Saido-Sakanaka, J. Ishibashi, E. Momotani, Peptides 2004, 25, 19-27.
9. V. G. Chinchar, L. Bryan, U. Silphadaung, Virology 2004, 323, 268-275.
10. R. E. W. Hancock, Lancet 1997, 349, 418-422.
11. R. Sinha Roy, A. M. Gehring, J. C. Milne, P. J. Belshaw, C. T. Walsh, Nat. Prod. Rep. 1999, 16, 249-263.
12. A. Bayer, S. Freund, G. Nicholson, G. Jung, Angew. Chem. Int. Ed. Engl. 1993, 32, 1336-1339.
13. P. Yorgey, J. Lee, J. Kordel, E. Vivas, et al., Proc. Natl Acad. Sci. USA 1994, 91, 4519-4523.
14. O. Genilloud, F. Moreno, R. Kolter, J. Bacteriol. 1989, 171, 1126-1135.
15. M. C. Garrido, M. Herrero, R. Kolter, F. Moreno, EMBO J. 1988, 7, 1853-1862.
16. Y. M. Li, J. C. Milne, L. L. Madison, R. Kolter, C. T. Walsh, Science 1996, 274, 1188-1193.
17. S. R. Ranabir, L. K. Neil, C. M. Jill, T. W. Christopher, Chem. Biol. 1999, 6, 305-318.
18. M. Stanchev, S. Tabakova, G. Videnov, E. Golovinsky, G. Jung, Arch. Pharm. Pharm. Med. Chem. 1999, 332, 297-304.
19. A. Andreani, V. Cavrini, G. Giovanninetti, A. M. Palenzona, L. Franchi, Farmaco 1975, 30, 440-445.
20. R. J. Dimmock, S. N. Pandey, J. W. Quail, Eur J. Med. Chem. 1995, 30, 303-306.
21. E. W. Koneman, S. D. Allen, W. C. Winn Colour Atlas and Textbook of Diagnostic Microbiology, Lippincott Raven Pub., Philadelphia, 1997, pp. 86-856.
22. NCCLS, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; 2002, Approved Standard, 2nd Ed., NCCLS document M27-A2 [ISBN 1-56238-469-4].
23. J. L. Carballo, Z. L. Hernández-Inda, P. Pérez, M. D. García-Grávalos, BMC Biotechnol. 2002, 2, 17.
24. M. C. Calleja, G. Persoone, Altern Lab Anim 1992, 20, 396-405.
25. M. I. Choudhary, W. J. Thomsen, Bioassay Techniques For Drug Development, Harwood Academic Publishers, 2001, pp. 9-10.
26. Trimmed Spearman-Karber program version 1.5., Ecological Monitoring Research Division, Environmental Monitoring Systems Laboratory, United States Environmental Protection Agency.
27. B. Brayn, M. Timothy, S. Tore, General and Applied Toxicology, Second Edition, 2000, Vol. 1, Part 1, pp. 52-53.